NCT05738590 is a clinical trial of muscle biopsy in Inflammatory Muscle Disease, sponsored by Assiut University.

Who is sponsoring NCT05738590?

NCT05738590 is sponsored by Assiut University.

What drugs are being tested in NCT05738590?

Interventions in NCT05738590: muscle biopsy.

What condition does NCT05738590 study?

NCT05738590 studies Inflammatory Muscle Disease.

Is NCT05738590 still recruiting?

NCT05738590 is currently status unknown. Last updated 22 February 2023.

Last reviewed 2023-02-22 · How we verify

NCT05738590

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Inflammatory and Degenerative Muscle Disease

Status unknown Last updated 22 February 2023

What this trial tests

trial testing muscle biopsy in Inflammatory Muscle Disease in 60 participants. Status unknown.

Timeline

1 April 2023

Primary endpoint
31 March 2024

28 May 2024

Quick facts

Lead sponsor	Assiut University
Status	Status unknown
Study type	OBSERVATIONAL
Enrollment	60
Start date	1 April 2023
Primary completion	31 March 2024
Estimated completion	28 May 2024

Drugs / interventions tested

muscle biopsy

Conditions studied

Inflammatory Muscle Disease — all drugs for Inflammatory Muscle Disease →

Sponsor

Assiut University

Who can join

Adults 18 to 75, any sex, with Inflammatory Muscle Disease. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Correlation between clinical , ultrasonographical, neurophysiological and histopathological findings in muscle diseases of different etiologies.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other trials of muscle biopsy

Trials testing the same drug.

NCT03531554 — Acute Nutritional Ketosis in VLCAD Deficiency · NA · completed

Other Assiut University trials

Trials by the same sponsor.

NCT07423312 — Lead Exposure and Multiple Sclerosis · not yet recruiting
NCT07234526 — Usage of Glucose Fluctuations as a Prognostic Marker in Septic Shock Patients · not yet recruiting
NCT07273214 — Knowledge, Attitude and Practice of Third Trimester Pregnant Mothers Towards Self-Medication in Assiut, Egypt · not yet recruiting
NCT07194863 — Efficacy of Essential Phospholipid Versus Betaine HCL/L-Glutamic Acid in MAFLD · not yet recruiting
NCT07053709 — Screening for Hyperuricemia in Patients With Metabolic Associated Fatty Liver Disease (MAFLD) · not yet recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT05738590 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Assiut University
Last refreshed: 22 February 2023

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05738590.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing